NOVANTA INC

NASDAQ: NOVT (Novanta Inc.)

Last update: 2 hours ago

113.87

-0.53 (-0.46%)

Previous Close 114.40
Volume 313,945
Price / Sales 4.46
Price / Book 2.77
52 Weeks Range
98.27 (-13%) — 176.38 (54%)
Profit Margin 7.42%
Operating Margin (TTM) 12.84%
Diluted EPS (TTM) 1.95
Quarterly Revenue Growth (YOY) 1.10%
Quarterly Earnings Growth (YOY) 44.50%
Total Debt/Equity (MRQ) 57.49%
Current Ratio (MRQ) 2.56
Operating Cash Flow (TTM) 157.37 M
Levered Free Cash Flow (TTM) 152.43 M
Return on Assets (TTM) 5.75%
Return on Equity (TTM) 9.73%

AIStockmoo Score

-0.9
Value 30% -0.6
From our AI Insight report's view of expected return against risk. info NA
Priced high for its earnings growth. info
Implied Growth info NA
Cheaper than its usual valuation. info
Low debt. Ample short-term liquidity. Positive cash flow. info
Earns below its cost of capital. Returns on capital falling. info
Timing 30% -1.1
From our AI technical analysis of the chart. info NA
Uptrend over the past year. Far below its 52-week high. info
Candle Patterns info NA
Trend for Your Holding Period info NA
Sentiment 20% 0.2
No recent price targets, so based on how targets have been revised. info
Recent news mixed or neutral. info
Smart Money 20% -1.1
Insider Activity info NA
Institutions net -0.82% of shares in their latest 13F filings: 217 holders increased, 164 decreased (quarter to 30 Sep 2026). info
Short interest +7.3% from 31 Aug to 30 Oct 2026, 14.8 days to cover (FINRA). info
Market and sector conditions are poor.
Market environment cautious. info
Sector lagging the market.
The pillars agree, so the score is strengthened.
Not in score
Price is low against its 52-week average. Down over 5 years. info
Trend down on all three terms. Short-term momentum falling. info
No clear signal from support and resistance. info
Final Score -0.88

Market Trend

Short Term Medium Term
Industry Scientific & Technical Instruments (US) Mixed Bullish
Scientific & Technical Instruments (Global) Mixed Bullish
Stock Novanta Inc. Mixed Mixed

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
NOVT - - - 2.77
CGNX - 0.54% - 4.89
SOTK - - - 3.14
ITRI - - - 2.57
MKSI - 0.48% - 4.44
ELSE - - - -

Select this tab to load the latest available analysis.

Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.

Sector Technology
Industry Scientific & Technical Instruments
Investment Style Small Growth
% Held by Insiders 0.86%
% Held by Institutions 105.06%

No data within this time range.

Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
FARRELL MATTHEW - - 0 0
Aggregate Net Quantity 0
Aggregate Net Value ($) 0
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) -
Name Holder Date Type Quantity Price Value ($)
FARRELL MATTHEW Director 03 Nov 2026 Option execute 241 - -

Institutions

Institutional ownership: 130.30%

Positions Holders Shares
Increased 217 3,937,317
Decreased 164 3,836,862
New 45 576,313
Sold out 46 986,780

SEC 13F filings via Nasdaq, latest filings up to 30 Sep 2026. Filings arrive up to 45 days after each quarter.

Short Interest

Settlement Shares Days to cover
30 Oct 2026 5,248,696 14.8
15 Oct 2026 5,240,079 10.7
30 Sep 2026 5,144,846 12.4
15 Sep 2026 4,972,389 17.4
31 Aug 2026 4,891,805 14.3
14 Aug 2026 4,796,334 10.0

FINRA short interest via Nasdaq, reported twice a month.

3 Positive 1 Negative 8 Neutral
Date Type Details
10 Nov 2026 Yahoo Finance Novanta Stock Earnings Beat Keeps Riverpoint Integration In Focus
Novanta reported Q3 2026 sales of US$305.01 million with GAAP net income of US$2.02 million, while adjusted metrics and revenue topped analyst expectations, and management reiterated 2026 revenue guidance alongside Q4 forecasts. The recent period put Riverpoint Medical at the center of Novanta's…
10 Nov 2026 Yahoo Finance Novanta Inc (NOVT) Q3 2026 Earnings Call Highlights: Record Margins, Strong Bookings and a ...
Novanta Inc (NOVT) delivered 23% revenue growth and a record 26% adjusted EBITDA margin in Q3 2026, but a production pause at its Stockport facility clouds the near-term gross margin outlook.
10 Nov 2026 Yahoo Finance Novanta (NOVT) Q3 2026 Earnings Call Transcript
Record margins and medical momentum stand out, but a U.K. plant slowdown adds a clear headwind.
10 Nov 2026 Yahoo Finance What Novanta (NOVT) Said on Its Q3 Earnings Call
Novanta (NASDAQ:NOVT) reported third-quarter revenue growth of 23% and its strongest organic growth in more than three years, as demand for robotics and advanced manufacturing products helped offset weakness in precision medicine. The company also completed its largest acquisition, Riverpoint Medica…
10 Nov 2026 Yahoo Finance Novanta to Present at the Jefferies Global Healthcare Conference on Wednesday, November 18, 2026
BOSTON, November 10, 2026--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are…
10 Nov 2026 Yahoo Finance Novanta (NOVT) to report earnings tomorrow: here is what to expect
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) will be reporting results this Monday afternoon. Here’s what to expect.
10 Nov 2026 Yahoo Finance Novanta Inc. Q3 2026 Earnings Call Summary
Moby summary of Novanta Inc.'s Q3 2026 earnings call…
09 Nov 2026 Yahoo Finance Novanta (NOVT) Q3 Earnings and Revenues Surpass Estimates
Novanta (NOVT) delivered earnings and revenue surprises of +8.25% and +1.50%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
09 Nov 2026 Yahoo Finance Novanta’s (NASDAQ:NOVT) Q3 2026 sales beat estimates but guides down full-year adjusted EPS
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) announced better-than-expected revenue in Q3 2026, with revenue up 23.1% year on year to $305 million. The company expects next quarter’s revenue to be around $309 million, close to analysts’ consensus estimates. Its non-GAAP…
09 Nov 2026 Yahoo Finance Novanta: Q3 Earnings Snapshot
(NOVT) on Monday reported net income of $2 million in its third quarter.The Bedford, Massachusetts-based company said it had profit of 5 cents per share.
09 Nov 2026 Yahoo Finance Novanta Announces Financial Results for the Third Quarter 2026
BOSTON, November 09, 2026--Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2026…
31 Oct 2026 Yahoo Finance What Did It Take To Hold Novanta Stock?
For questions about this article or underlying research, email [email protected].
28 Oct 2026 Yahoo Finance Littelfuse (LFUS) Beats Q3 Earnings Estimates
Littelfuse (LFUS) delivered earnings and revenue surprises of +16.97% and -2.95%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
27 Oct 2026 Yahoo Finance CTS (CTS) Q3 Earnings and Revenues Top Estimates
CTS (CTS) delivered earnings and revenue surprises of +16.67% and +2.32%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
22 Oct 2026 Yahoo Finance Novanta (NOVT): buy, sell, or hold post Q2 earnings?
Novanta has been treading water for the past six months, recording a small return of 4.1% while holding steady at $138.70…
20 Oct 2026 Yahoo Finance Novanta to Present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026
BOSTON, October 20, 2026--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled…
15 Oct 2026 Yahoo Finance 1 Cash-Heavy Stock to Keep an Eye On and 2 We Question
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.
13 Oct 2026 Yahoo Finance Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call
BOSTON, October 13, 2026--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2026 results after the close of U.S. financial markets on Monday, November 9, 2026…
10 Oct 2026 Yahoo Finance 3 Robotics Stocks Investors Are Watching For The Next AI Automation Wave
Global capital is again chasing artificial intelligence, and this time the spotlight is on robotics and automation pure plays that could sit in the slipstream of a potential US$100b SoftBank AI push. Middle Eastern money, a possible Roze IPO and fresh acquisition firepower together create a feeling…
Show more

Recent Signals candle patterns and EMA crosses

▼ Death cross Last session · 16 Nov
Long term · EMA 50/200
The 50-day EMA crossed below the 200-day, a widely watched sign that the long-term trend has turned down.

AI Technical Analysis

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria